The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda
- 17 Feb 2017 Status changed from not yet recruiting to recruiting.
- 16 Feb 2017 Planned End Date changed from 1 May 2017 to 1 Jan 2018.
- 16 Feb 2017 Planned primary completion date changed from 1 May 2017 to 1 Jan 2018.